Concepedia

Lizhi Lin

LL

Statistics

Publications

5

Citations

148

H-Index

5

Active since

2020

Affiliations

First Affiliated Hospital of Wenzhou Medical University(Current)

Wenzhou Medical University

Lizhi Lin is an author at First Affiliated Hospital of Wenzhou Medical University specializing in tumor biology, cancer genetics, and gene expression.

ORCID

Top concepts

Publications per year

2020–2021

5

Publications

5

KCNN4 is a diagnostic and prognostic biomarker that promotes papillary thyroid cancer progression

Jialiang Wen, Bangyi Lin, Lizhi Lin et al. · Aging · 2020 · 68 citations · Full text

Phospholipase C Delta 3 inhibits apoptosis and promotes proliferation, migration, and invasion of thyroid cancer cells via Hippo pathway

Lizhi Lin, Jialiang Wen, Bangyi Lin et al. · Acta Biochimica et Biophysica Sinica · 2021 · 23 citations

Eva‐1 homolog A promotes papillary thyroid cancer progression and epithelial‐mesenchymal transition via the Hippo signalling pathway

Bangyi Lin, Jialiang Wen, Chen Zheng et al. · Journal of Cellular and Molecular Medicine · 2020 · 20 citations · Full text

, , +14

<p>MFAP2 is a Potential Diagnostic and Prognostic Biomarker That Correlates with the Progression of Papillary Thyroid Cancer</p>

Si Yang Dong, Hao Chen, Lizhi Lin et al. · Cancer Management and Research · 2020 · 20 citations · Full text

Genetic landscape of breast cancer and mutation tracking with circulating tumor DNA in Chinese women

Yinghao Wang, Lizhi Lin, Linhong Li et al. · Aging · 2021 · 17 citations · Full text

1–5 of 5